Literature DB >> 6238016

The influence of radiation therapy on T-lymphocyte subpopulations defined by monoclonal antibodies.

G Job, M Pfreundschuh, M Bauer, K zum Winkel, W Hunstein.   

Abstract

We studied the influence of radiation therapy on lymphocyte subpopulations in 17 patients undergoing adjuvant radiation therapy for primary breast cancer, and eight patients receiving brachytherapy and external beam irradiation for primary cancer of the uterus. Radiation therapy reduced B- and T-lymphocytes in proportion to the total lymphocyte population so that their percentages remained unchanged. Determination of helper and suppressor T-lymphocytes before, during and 6 months after completion of radiotherapy revealed that in both groups of patients suppressor T-lymphocytes were more resistant to and recovered faster after radiotherapy. This resulted in a decline of the "immunoregulatory balance" (helper/suppressor ratio). Although this ratio had been higher in both groups of patients than in healthy age- and sex-matched controls before therapy, it became normal and subnormal during and after radiotherapy. The clinical significance of the differential influence of radiotherapy on T-lymphocyte subpopulations remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238016     DOI: 10.1016/0360-3016(84)90205-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Blood lymphocyte subsets after the first fraction in patients given hyperfractionated total body irradiation for bone marrow transplantation.

Authors:  T Girinsky; G Socie; J M Cosset; E P Malaise
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

2.  Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.

Authors:  R E Donahue; S W Kessler; D Bodine; K McDonagh; C Dunbar; S Goodman; B Agricola; E Byrne; M Raffeld; R Moen
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.